Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Personalis, Inc. - Common Stock
(NQ:
PSNL
)
8.839
-0.161 (-1.78%)
Streaming Delayed Price
Updated: 11:57 AM EST, Feb 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference
February 17, 2026
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From
Personalis, Inc.
Via
Business Wire
Top movers in Tuesday's pre-market session
↗
February 10, 2026
Via
Chartmill
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test
↗
February 10, 2026
Medicare will reimburse the company’s NeXT Personal molecular residual disease (MRD) test when used to monitor patients with early to mid-stage non-small cell lung cancer (NSCLC).
Via
Stocktwits
Topics
Artificial Intelligence
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance
February 10, 2026
From
Personalis, Inc.
Via
Business Wire
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit
↗
February 03, 2026
This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets.
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares
↗
February 02, 2026
This semiconductor company provides integrated RF and mixed-signal solutions for broadband, wireless, and industrial connectivity.
Via
The Motley Fool
Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors
February 02, 2026
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2026
From
Personalis, Inc.
Via
Business Wire
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
January 12, 2026
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
January 08, 2026
From
Personalis, Inc.
Via
Business Wire
Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
December 17, 2025
From
Personalis, Inc.
Via
Business Wire
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
December 11, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 18, 2025
From
Personalis, Inc.
Via
Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 10, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday
↗
November 10, 2025
Via
Benzinga
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
November 10, 2025
From
Personalis, Inc.
Via
Business Wire
What's going on in today's after hours session
↗
November 04, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Personalis Reports Third Quarter 2025 Financial Results
November 04, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Announce Third Quarter 2025 Financial Results
October 21, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing
October 16, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2025
From
Personalis, Inc.
Via
Business Wire
CATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal Test
September 10, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing
September 03, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate in Upcoming Investor Conferences
August 27, 2025
From
Personalis, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 06, 2025
Via
Benzinga
The market is filled with gapping stocks in Wednesday's session.
↗
August 06, 2025
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Discover the top movers in Wednesday's pre-market session.
↗
August 06, 2025
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
August 06, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
